Compare the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy Versus Rosuvastatin Monotherapy in Korean Patients With Left Ventricular Diastolic Dysfunction and Hyperlipidemia

NCT04433533 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Left Ventricular Diastolic Dysfunction
Hyperlipidemias

Interventions

DRUG: Rosuvastatin 20
DRUG: Rosuvamibe 10/10

Sponsor

Yonsei University